When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ARQT - Arcutis launches plaque psoriasis therapy Zoryve in US
Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics ( NASDAQ: ARQT ) said it launched its plaque psoriasis cream Zoryve in the U.S.
In July, the U.S. FDA approved Zoryve (roflumilast) cream 0.3% for topical use to treat plaque psoriasis in people aged 12 years and older.
The company said the product was available via ZORYVE Direct pharmacies — contracted pharmacy partners that help commercially insured individuals get access to the drug — and will be available for ordering at pharmacies nationwide no later than Aug. 15.